Log in

NASDAQ:EIGREiger Biopharmaceuticals Earnings Date, Estimates & History

$9.47
+0.20 (+2.16 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.08
Now: $9.47
$9.47
50-Day Range
$9.30
MA: $10.70
$13.37
52-Week Range
$4.55
Now: $9.47
$15.82
Volume204,400 shs
Average Volume364,986 shs
Market Capitalization$237.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Earnings

Eiger Biopharmaceuticals (NASDAQ:EIGR) Earnings Information

Eiger Biopharmaceuticals last issued its earnings data on May 7th, 2020. The biotechnology company reported ($0.62) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.76) by $0.14. Eiger Biopharmaceuticals has generated ($3.08) earnings per share over the last year. Eiger Biopharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Eiger Biopharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Eiger Biopharmaceuticals (NASDAQ:EIGR) Earnings Estimates

2020 EPS Consensus Estimate: ($3.36)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.92)($0.70)($0.81)
Q2 20202($0.96)($0.71)($0.84)
Q3 20202($0.97)($0.72)($0.85)
Q4 20202($1.03)($0.71)($0.87)

Eiger Biopharmaceuticals (NASDAQ EIGR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/2020
(Estimated)
       
5/7/2020Q1 2020($0.7550)($0.62)($0.62)N/A
3/13/202012/31/2019($0.39)($0.69)($0.69)$2.48 millionN/A
11/7/2019Q3($0.7480)($0.76)($0.76)N/A
8/8/2019Q2 2019($0.7330)($0.75)($0.75)N/A
5/9/2019Q1($0.95)($0.90)($0.90)N/A
3/14/2019Q4($0.8170)($0.92)($0.92)N/A
11/9/20189/30/2018($0.77)($1.20)($1.20)N/A
8/10/2018Q2 2018($0.82)($0.82)($0.82)N/A
5/11/2018Q1 2018($0.96)($0.84)($0.84)N/A
3/12/2018Q4 2017($1.02)($1.11)($1.11)N/A
11/9/2017Q3 2017($1.28)($1.10)($1.10)N/A
8/14/2017Q2 2017($1.2840)($1.33)($1.33)N/A
5/12/2017Q1 2017($1.35)($1.34)($1.34)N/A
3/23/2017Q4 2016($1.3830)($1.53)($1.53)N/A
11/8/2016Q3 2016($1.21)($1.49)($1.49)N/A
8/10/2016Q2($1.17)($1.87)($1.87)N/A
5/16/2016Q1($1.69)($10.42)($10.42)N/A
11/9/2015Q3 2015($3.30)($4.05)($4.05)N/A
8/11/2015Q2($0.32)($0.69)($0.69)N/A
5/14/2015Q1 2015($6.90)($10.64)($10.64)N/A
3/31/2015Q414($0.36)($0.49)($0.49)N/A
11/12/2014Q3 2014($0.39)($0.40)($0.40)N/A
8/7/2014Q2 2014($0.39)($0.38)($0.38)N/A
5/13/2014Q1 2014($0.44)($0.58)($0.56)N/A
3/31/2014Q4 2013($0.47)($7.96)($7.96)Listen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.